2019
$257M
from 17 investors over 17 rounds
Thrive, An Exact Sciences Company raised $257M on July 29, 2020
Investors: Sands Capital Management, Section 32, T. Rowe Price, Perceptive Advisors, The Invus Group, Third Rock Ventures and Lux Capital
Thrive, An Exact Sciences Company raised $110M on May 30, 2019
Investors: The Blue Venture Fund, 苏州凯风正德投资管理有限公司, Gamma3 Comunicação e Tecnologia, Biomatics Capital, Exact Sciences, Section 32, Camden Partners, Third Rock Ventures, The Invus Group and Casdin Capital, LLC